Jun 22 2022

Nanomix Initiates New Clinical Study for the eLab S1 Panel

Read More • 9:00 am EDT

Jun 14 2022

Nanomix Receives IVDR Certification for the eLab Analyzer

Read More • 9:00 am EDT

May 26 2022

Nanomix Granted CE Mark for eLab S1 Assay Panel for Whole Blood Samples

Read More • 8:30 am EDT

May 23 2022

Nanomix Announces Upgrade to OTCQB® Venture Market

Read More • 8:30 am EDT

May 20 2022

Nanomix Receives CE Mark for its eLab COVID-19 Rapid Point-of-Care Antigen Panel

Read More • 8:30 am EDT

Mar 30 2022

Nanomix Appoints Vidur Sahney as Chief Operating Officer

Read More • 8:00 am EDT

Mar 25 2022

Nanomix Corporation Announces Securities Purchase Agreement With GHS Investments for up to $3.0 Million

Read More • 8:00 am EDT

Mar 22 2022

Nanomix to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

Read More • 8:00 am EDT

Mar 02 2022

Nanomix Completes 1-for-173 Reverse Stock Split

Read More • 7:00 am EST

Dec 08 2021

Nanomix Announces UK MHRA Registration for New Point of Care System

Read More • 4:05 pm EST

Dec 01 2021

Nanomix Submits Emergency Use Authorization Application for its Rapid Point-of-Care Antigen Panel to Detect COVID-19

Read More • 4:05 pm EST

Nov 15 2021

Nanomix Completes Changes to Corporate Name and Ticker Symbol

Read More • 4:00 pm EST